Disease Intelligence
Alzheimer
Alzheimer: 110 indexed trials, 25 recruiting studies, 96 sponsors and 20 countries in the current NeuroRisk corpus.
Request Alzheimer enterprise brief →Indexed trials110
Recruiting25
Sponsors96
Countries20
Analytical signals
Opportunity90.84
Momentum108.84
Publications24
2030 signal217.68
Model-derived signals require context and are not medical advice or guaranteed forecasts.
Leading indexed sponsors
Eli Lilly and Company3 indexed studies1 recruiting
Hoffmann-La Roche3 indexed studies0 recruiting
Massachusetts General Hospital2 indexed studies0 recruiting
University Hospital, Lille2 indexed studies1 recruiting
Wyeth is now a wholly owned subsidiary of Pfizer2 indexed studies0 recruiting
GlaxoSmithKline2 indexed studies1 recruiting
HealthPartners Institute2 indexed studies0 recruiting
University of Minnesota2 indexed studies0 recruiting
Biogen2 indexed studies1 recruiting
AstraZeneca2 indexed studies0 recruiting
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2 indexed studies0 recruiting
Columbia University2 indexed studies0 recruiting
Enterprise intelligence
Unlock comparative analysis, exports, API workflows and evidence-linked briefs tailored to your organization.
Request enterprise access →